Compile Data Set for Download or QSAR
Report error Found 3388 with Last Name = 'sciabola' and Initial = 's'
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50205990(CHEMBL395429 | OXYTOCIN)
Affinity DataEC50:  0.0400nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50179992(CHEMBL3814395)
Affinity DataEC50:  4.80nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50179993(CHEMBL3814165)
Affinity DataEC50:  24nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50179994(CHEMBL3814126)
Affinity DataEC50:  15nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50180154(CHEMBL3814617)
Affinity DataEC50:  26nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50180013(CHEMBL3814904)
Affinity DataEC50: >1.00E+3nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50180015(CHEMBL3813883)
Affinity DataEC50:  4.20nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50180155(CHEMBL3813894)
Affinity DataEC50:  0.990nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50180156(CHEMBL3813714)
Affinity DataEC50: >1.00E+3nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50180160(CHEMBL3815099)
Affinity DataEC50:  0.590nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50180151(CHEMBL3813707)
Affinity DataEC50:  2.40nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50044676(CHEMBL439044)
Affinity DataEC50:  0.0400nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50180014(CHEMBL3814744)
Affinity DataEC50:  0.520nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50180159(CHEMBL3814232)
Affinity DataEC50:  175nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50180132(CHEMBL3814633)
Affinity DataEC50:  0.470nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50180157(CHEMBL3813879)
Affinity DataEC50:  283nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50180161(CHEMBL3813729)
Affinity DataEC50:  7nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50180164(CHEMBL3814120)
Affinity DataEC50:  11nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50180158(CHEMBL3813858)
Affinity DataEC50:  16nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50180162(CHEMBL3813771)
Affinity DataEC50:  0.290nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50180165(CHEMBL3813722)
Affinity DataEC50:  5.5nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50180163(CHEMBL3813982)
Affinity DataEC50:  8nMAssay Description:Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2017
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM490009(US10966980, Example 263)
Affinity DataIC50: 0.00200nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM490011(US10966980, Example 265)
Affinity DataIC50: 0.00200nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489909(US10966980, Example 163)
Affinity DataIC50: 0.00300nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489965(US10966980, Example 219)
Affinity DataIC50: 0.00300nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489982(US10966980, Example 236)
Affinity DataIC50: 0.00300nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489983(US10966980, Example 237)
Affinity DataIC50: 0.00300nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489985(US10966980, Example 239)
Affinity DataIC50: 0.00300nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489960(US10966980, Example 214)
Affinity DataIC50: 0.00400nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489998(US10966980, Example 252)
Affinity DataIC50: 0.00400nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489916(US10966980, Example 170)
Affinity DataIC50: 0.00500nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489922(US10966980, Example 176)
Affinity DataIC50: 0.00500nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489940(US10966980, Example 194)
Affinity DataIC50: 0.00500nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489974(US10966980, Example 228)
Affinity DataIC50: 0.00500nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489977(US10966980, Example 231)
Affinity DataIC50: 0.00500nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489986(US10966980, Example 240)
Affinity DataIC50: 0.00500nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM490006(US10966980, Example 260)
Affinity DataIC50: 0.00500nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM490008(US10966980, Example 262)
Affinity DataIC50: 0.00500nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM490010(US10966980, Example 264)
Affinity DataIC50: 0.00500nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489941(US10966980, Example 195)
Affinity DataIC50: 0.00600nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489978(US10966980, Example 232)
Affinity DataIC50: 0.00600nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489987(US10966980, Example 241)
Affinity DataIC50: 0.00600nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489994(US10966980, Example 248)
Affinity DataIC50: 0.00600nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM490005(US10966980, Example 259)
Affinity DataIC50: 0.00600nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489906(US10966980, Example 160)
Affinity DataIC50: 0.00700nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489934(US10966980, Example 188)
Affinity DataIC50: 0.00700nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489968(US10966980, Example 222)
Affinity DataIC50: 0.00700nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489901(US10966980, Example 155)
Affinity DataIC50: 0.00800nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Pfizer

US Patent
LigandPNGBDBM489920(US10966980, Example 174)
Affinity DataIC50: 0.00800nMAssay Description:Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
Go to US Patent

Displayed 1 to 50 (of 3388 total ) | Next | Last >>
Jump to: